The National Drug Abuse Clinical Trials Network: New England Consortium Node08/01/2023 - 02/28/2025 (Subcontract PI)
PI:
Zoe M. Weinstein, MD, MSYale University School of Medicine NIH NIDA5UG1DA015831-22
NorthStar Node of the Clinical Trials Network--0098A03/01/2022 - 02/28/2025 (Subcontract PI)
PI:
Zoe M. Weinstein, MD, MSHennepin Healthcare Research Institute NIH NIDA
NorthStar Node of the Clinical Trials Network--0098B03/01/2022 - 02/28/2025 (Subcontract PI)
PI:
Zoe M. Weinstein, MD, MSHennepin Healthcare Research Institute NIH NIDA
NIDA CTN-0131: Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment -A Randomized Pragmatic Hybrid Effectiveness/Implementation Trial08/01/2023 - 02/29/2024 (Subcontract PI)
PI:
Zoe M. Weinstein, MD, MSYale University School of Medicine NIH NIDA
Health Systems Node of the NIDA Clinical Trials Network (Primary Care Opioid Use Disorders Treatment (PROUD) Trial -Dissemination Activities 1)09/01/2022 - 02/29/2024 (Subcontract PI)
PI:
Zoe M. Weinstein, MD, MSKaiser Permanente NIH NIDA3UG1DA040314-08S1
Preventing Bacterial and Viral Infections Among Injection Drug users09/09/2016 - 04/30/2020 (Multi-PI)
PI:
Zoe M. Weinstein, MD, MSTrustees of Boston University,CRC NIH NIDA
Next Generation Award for Adolescent Substance Use Prevention-Zoe Weinstein07/01/2014 - 06/30/2015 (PI)
American Board of Addiction Medicine Foundation